• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在使用加工速度测量的成年人中,不伴有抑郁的情况下,区分抑郁和 ADHD。

Differentiating depression and ADHD without depression in adults with processing-speed measures.

机构信息

Psychiatric Center Copenhagen, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark.

Västervik Sjukhus, Department of Psychiatry, Västervik, Sweden.

出版信息

Acta Neuropsychiatr. 2020 Oct;32(5):237-246. doi: 10.1017/neu.2020.17. Epub 2020 Apr 27.

DOI:10.1017/neu.2020.17
PMID:32338233
Abstract

OBJECTIVE

We evaluated processing-speed and shift-cost measures in adults with depression or attention-deficit hyperactivity disorder (ADHD) and monitored the effects of treatment. We hypothesised that cognitive-speed and shift-cost measures might differentiate diagnostic groups.

METHODS

Colour, form, and colour-form stimuli were used to measure naming times. The shift costs were calculated as colour-form-naming time minus the sum of colour- and form-naming times. Measurements were done at baseline and end point for 42 adults with depression and 42 with ADHD without depression. Patients with depression were treated with transcranial pulsed electromagnetic fields and patients with ADHD with methylphenidate immediate release.

RESULTS

During depression treatment, reductions in naming times were recorded weekly. One-way analysis of variance indicated statistical between-group differences, with effect sizes in the medium range for form and colour-form. In both groups, naming times were longer before than after treatment. For the ADHD group, shift costs exceeded the average-normal range at baseline but were in the average-normal range after stabilisation with stimulant medication. For the depression group, shift costs were in the average-normal range at baseline and after treatment. Baseline colour-form-naming times predicted reductions in naming times for both groups, with the largest effect size and index of forecasting efficiency for the ADHD group.

CONCLUSIONS

The cognitive-processing-speed (colour-form) and shift-cost measures before treatment proved most sensitive in differentiating patients with depression and ADHD. Reductions in naming times for the depression group were suggested to reflect improved psychomotor skills rather than improved cognitive control.

摘要

目的

我们评估了抑郁症或注意力缺陷多动障碍(ADHD)患者的处理速度和转换成本指标,并监测了治疗效果。我们假设认知速度和转换成本指标可能会区分不同的诊断组。

方法

使用颜色、形状和颜色-形状刺激来测量命名时间。转换成本的计算方法是颜色-形状命名时间减去颜色和形状命名时间的总和。对 42 名抑郁症患者和 42 名无抑郁症的 ADHD 患者进行了基线和终点的测量。抑郁症患者接受经颅脉冲电磁场治疗,ADHD 患者接受哌醋甲酯即刻释放治疗。

结果

在抑郁症治疗期间,每周记录命名时间的减少。单因素方差分析表明存在组间统计学差异,形状和颜色-形状的效应大小处于中等范围。在两组中,治疗前的命名时间都比治疗后长。对于 ADHD 组,转换成本在基线时超过了平均正常范围,但在用兴奋剂药物稳定后处于平均正常范围内。对于抑郁症组,转换成本在基线和治疗后都处于平均正常范围内。基线颜色-形状命名时间预测了两组命名时间的减少,ADHD 组的效应量和预测效率指数最大。

结论

治疗前的认知处理速度(颜色-形状)和转换成本指标在区分抑郁症和 ADHD 患者方面最为敏感。抑郁症组命名时间的减少表明心理运动技能的改善,而不是认知控制的改善。

相似文献

1
Differentiating depression and ADHD without depression in adults with processing-speed measures.在使用加工速度测量的成年人中,不伴有抑郁的情况下,区分抑郁和 ADHD。
Acta Neuropsychiatr. 2020 Oct;32(5):237-246. doi: 10.1017/neu.2020.17. Epub 2020 Apr 27.
2
Processing speed can monitor stimulant-medication effects in adults with attention deficit disorder with hyperactivity.处理速度可监测患有注意力缺陷多动障碍的成年人的兴奋剂药物疗效。
Nord J Psychiatry. 2017 May;71(4):296-303. doi: 10.1080/08039488.2017.1280534. Epub 2017 Feb 7.
3
Methylphenidate effects on processing speed in a clinical sample of adults with ADHD and substance use disorder: a pilot study.哌甲酯对患有注意力缺陷多动障碍和物质使用障碍的成年临床样本处理速度的影响:一项初步研究。
Nord J Psychiatry. 2019 Feb;73(2):118-124. doi: 10.1080/08039488.2019.1573922. Epub 2019 Mar 12.
4
AQT cognitive speed and processing efficiency differentiate adults with and without ADHD: a preliminary study.AQT 认知速度和处理效率可区分 ADHD 患者和非 ADHD 患者:一项初步研究。
Int J Psychiatry Clin Pract. 2011 Sep;15(3):219-27. doi: 10.3109/13651501.2011.582538. Epub 2011 Jun 27.
5
Validation of the AQT color-form additive model for screening and monitoring pharmacological treatment of ADHD.验证 AQT 颜色-形式添加剂模型在 ADHD 药物治疗的筛选和监测中的应用。
J Atten Disord. 2013 Apr;17(3):187-93. doi: 10.1177/1087054711428075. Epub 2011 Dec 29.
6
Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD.评估 ADHD 青少年使用奥昔哌汀控释片治疗时的认知领域。
Child Neuropsychol. 2014;20(3):319-27. doi: 10.1080/09297049.2013.790359. Epub 2013 May 2.
7
Naming speed performance and stimulant effects indicate effortful, semantic processing deficits in attention-deficit/hyperactivity disorder.命名速度表现和兴奋剂效应表明注意缺陷多动障碍存在费力的语义加工缺陷。
J Abnorm Child Psychol. 2000 Jun;28(3):237-52. doi: 10.1023/a:1005192220001.
8
Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment.注意力缺陷多动障碍成人在兴奋剂治疗前后的视觉注意力。
Psychol Med. 2019 Nov;49(15):2617-2625. doi: 10.1017/S0033291718003628. Epub 2018 Dec 18.
9
OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.奥罗莫苯丙胺对 ADHD 成人特定执行功能缺陷的疗效:一项随机、安慰剂对照交叉研究。
Eur Neuropsychopharmacol. 2014 Apr;24(4):519-28. doi: 10.1016/j.euroneuro.2014.01.007. Epub 2014 Jan 18.
10
Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.兴奋剂药物对患有注意力缺陷/多动障碍的年轻人神经心理功能的影响。
J Clin Psychiatry. 2008 Jul;69(7):1150-6. doi: 10.4088/jcp.v69n0715.

引用本文的文献

1
Comorbidities and Disease Duration in Tourette Syndrome: Impact on Cognition and Quality of Life of Children.抽动秽语综合征的共病情况与病程:对儿童认知及生活质量的影响
Children (Basel). 2024 Feb 9;11(2):226. doi: 10.3390/children11020226.